Dysregulation of the Ubiquitin–Proteasome System (UPS) in ALS patients was first suspected following the identification of mutations in genes encoding ubiquilin 2 [238] and VCP [199], two proteins involved in protein clearance via the ubiquitin-proteasome pathway [239]. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.